US Pharma MarketingSwiss manufacturing, biotech industry so far unfazed by geopolitics
Pharma manufacturing in Switzerland appears to be unperturbed by the threat of tariffs but it might take several years before the impact of companies moving production to the US becomes clear. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and…
BASEL, Switzerland — Pharma manufacturing in Switzerland appears to be unperturbed by the threat of tariffs, but it might take several years before the impact of companies moving production to the US becomes clear.
According to ...
Source: Endpoints News